Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, et al. Neurofibromatosis type 2. Lancet. 2009;373(9679):1974–86. S0140–6736(09)60259–2 [pii] https://doi.org/10.1016/S0140-6736(09)60259-2.
2. Di Maio S, Akagami R. Prospective comparison of quality of life before and after observation, radiation, or surgery for vestibular schwannomas. J Neurosurg. 2009;111(4):855–62. https://doi.org/10.3171/2008.10.Jns081014.
3. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993;72(5):791–800. https://doi.org/10.1016/0092-8674(93)90406-g.
4. McClatchey AI, Giovannini M. Membrane organization and tumorigenesis–the NF2 tumor suppressor. Merlin Genes Dev. 2005;19(19):2265–77. https://doi.org/10.1101/gad.1335605.
5. Hung G, Li X, Faudoa R, Xeu Z, Kluwe L, Rhim JS, et al. Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. Int J Oncol. 2002;20(3):475–82.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献